Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chitosan mouthwash for plaque and gingival indices in fixed orthodontic retainer patients
IRCT20220726055561N1Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Nov 2022
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3 trial of chitosan in gingivitis, sponsored by Arak University of Medical Sciences. Primary endpoints: Plaque index change and Gingival index change. Started Nov 2022; status: completed.
02
Drugs
chitosan
03
Conditions
gingivitis
Beyond the preview
Go deeper on IRCT20220726055561N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220726055561N1.